Nickel is a major carcinogen that is implicated in tumor development through occupational and environmental exposure. Although the exact molecular mechanisms of carcinogenesis by low-level nickel remain unclear, inhibition of DNA repair is frequently considered to be a critical mechanism of carcinogenesis. Here, we investigated whether low concentrations of nickel would affect p53-mediated DNA repair, especially nucleotide excision repair. Our results showed that nickel inhibited the promoter binding activity of p53 on the downstream gene GADD45A, as a result of the disturbance of p53 oligomerization by nickel. In addition, we demonstrated that nickel exposure trigger the reduction of GADD45A-mediated DNA repair by impairing the physical interactions between GADD45A and proliferating cell nuclear antigen or xeroderma pigmentosum G. Notably, in the GADD45A-knockdown system, the levels of unrepaired DNA photoproducts were higher than wild-type cells, elucidating the importance of GADD45A in the nickel-associated inhibition of DNA repair. These results imply that inhibition of p53-mediated DNA repair can be considered a potential carcinogenic mechanism of nickel at low concentrations.
Introduction
Nickel compounds accumulate in the human body as a result of persistent exposure at low levels through inhalation or oral ingestion in many modern industrial processes, such as electroplating, welding and alloy production (1) . Moreover, recent studies have reported that exposure to airborne nickel in fine ambient particulate matter at low concentrations induces dysfunction in human tissues (2, 3) . Accordingly, the carcinogenicity of nickel in humans has been reported by various epidemiological studies on its occupational exposure (4, 5) . Indeed, nickel has been categorized as a carcinogenic heavy metal by the World Health Organization's International Agency for Research on Cancer (6). In modern society, humans have been spontaneously exposed to nickel via inhalation and ingestion over long terms and in low doses. Still, few studies have shown that chronic low-dose exposure to nickel has been associated with increased risk of diseases such as cancer (7) (8) (9) . In particular, with a report on the environmental and dietary exposure in human to nickel, ~200-300 µg/day on average (10) , the toxic effect of low-dose nickel should have to investigate actively for understanding its molecular mechanism and further for protecting human health from it.
Disturbance of genomic stability is one of the major causes of tumorigenesis, and consequently numerous protective mechanisms are crucial for cell survival (11) . Tumor suppressor p53 is the main multifunctional protein that responds to DNA damage and mutation, which may lead to cancer (12) . It has been suggested that p53 prevents cells from accumulating DNA damage by inducing pathways that result in cell cycle arrest, apoptosis and DNA repair; specifically, the speculation is that p53 regulates the downstream genes as a sequence-specific DNA-binding transcription factor (13) . Interestingly, controversial phenomena of p53-related activity have been suggested to elucidate nickel toxicity as accumulated p53 protein (14, 15) and alteration of p53 downstream genes (16, 17) . Thus, novel approached are needed for understanding the role of p53 in nickel-induced carcinogenesis, and herein we evaluated abnormal functional states of p53 under nickel exposure.
As one of the p53 downstream genes, the growth arrest and DNA-damage-inducible protein 45 alpha (GADD45A) is activated following stressful growth arrest conditions and treatment with DNA-damaging agents (18) . GADD45A enhances DNA repair by allowing repair complexes to access damaged DNA more effectively (18, 19) . Indeed, GADD45A has pleiotropic functions by interacting with various proteins such as proliferating cell nuclear antigen (PCNA), core histones, p21 (Waf1/Cip1), MAP three kinase 1 and Cdc2 (20, 21) . In particular, several studies, including our previous research, have demonstrated the direct interaction of GADD45A and PCNA in the DNA repair mechanism and have characterized the functions of this interaction (21) (22) (23) .
To maintain genomic integrity, DNA repair machineries are especially essential in preventing carcinogenesis (24) . The nucleotide excision repair (NER) pathway maintains genome stability by eliminating a wide variety of DNA lesions induced by exogenous toxicants such as ultraviolet (UV) radiation (25) . Various studies have reported that nickel inhibits the removal of UV-induced DNA damage by disturbing DNA repair proteins and affecting the NER process (26) (27) (28) . Several researchers, including our group, have described the importance of the p53-mediated NER mechanism for protection against mutagenesis (29) (30) (31) .
NER operates through pre-and post-incision NER complexes following different DNA damage recognition phases (24) . PCNA plays a vital role as a molecular adaptor in recruiting post-incision NER complexes (32) . In particular, PCNA is specifically loaded and interacts with xeroderma pigmentosum G (XPG), which is in a pre-incision NER complex and plays a crucial role in cleaving the 3′ site of damage in the NER pathway (33) . Importantly, Barreto et al. (34) demonstrated the physical interaction of mammalian XPG and GADD45A as well as the inhibition of GADD45A reporter activation in an XPG siRNA knockdown system. The accumulated evidence suggests that GADD45A, PCNA and XPG play important roles as one complex in the NER process.
The enhancement of carcinogenic action by nickel has been suggested with NER inhibition of DNA damage as a potential mechanism (35, 36) . Although various studies have frequently been discussed the relationship between nickel and DNA repair (27, 35, 37) , in the present study, we focused on the effects of low-dose nickel on interference in the p53-modulated NER process. In particular, we investigated the p53-mediated reduction of GADD45A interaction with major NER factors under nickel exposure. In this study, we firstly account for a carcinogenic mechanism of nickel at the molecular level that disrupts the maintenance of p53 functional form and interactions among key NER proteins.
Materials and methods

Cell culture and heavy metal treatment
RKO human colon cancer cell line (CRL-2577) was purchased from American Type Culture Collection (ATCC, Manassas, VA) and were authenticated before being frozen by ATCC. The cells were maintained in RPMI 1640 (Gibco, Grand Island, NY), supplemented with 10% fetal bovine serum (FBS) (Gibco), 10 000 U/ml penicillin and 10 000 μg/ml streptomycin (Gibco), in 5% CO 2 at 37°C. Normal human dermal fibroblasts (NHDF) were purchased from Lonza (Basel, Switzerland) and were authenticated before being frozen by Lonza. NHDF were cultured in Dulbecco's modified Eagle's medium (DMEM) with 4.5 g/l glucose and l-glutamine (Lonza) supplemented with 10% FBS (Invitrogen-Gibco, Grand Island, NY) and 1% antibiotics (Invitrogen-Gibco) at 37°C and 5% CO2. The culture medium was changed every other day. Sixteen hours after cell seeding, we treated the cells with nickel (II) acetate (Sigma-Aldrich, St. Louis, MO) or zinc chloride (Sigma-Aldrich).
Protein cross-linking assay
After lysis in buffer (150 mM NaCl, 0.5% NP40, 50 mM Tris-HCl, pH 8.0 and 5 mM EDTA), the cells were centrifuged and the supernatant was recovered. The 50 μg lysates were incubated with 0.04% glutaraldehyde on ice for 30 min. The reaction was stopped with sample buffer, and the samples were heated at 100°C for 5 min and resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis. Western blot analysis was performed with anti-p53 antibody DO-1 (Santa Cruz Biotechnology, Inc., Dallas, TX).
Electron microscopy
Transmission electron microscopy was used to observe the changes in p53 protein structure in response to nickel. We purified p53 proteins from a yeast vector, pEG(KT), that contained GST-tagged TP53. Each protein had treated 25 μM nickel (II) acetate (Sigma-Aldrich) or 5 μM zinc chloride (Sigma-Aldrich) on ice for 30 min. Before preparing the sample grids, it is necessary for each carbon-coated copper grid (Ted Pella, Redding, CA) to be glow-discharged to change its hydrophilic status. We placed 2.5 μl of a protein sample on a carbon-coated copper grid, stained with a 2% uranyl acetate for 30 s and completely dried it. The transmission electron microscopy images were observed at a magnification of 50 000× using a JEOL JEM2200FS microscope (Tokyo, Japan), and recorded on a F415 4k × 4× CCD camera (TVIPS, Germany). The size of each particle was measured by pixel length (0.488 nm/pixel).
Electrophoretic mobility shift assay
We used GADD45A-specific oligonucleotides (sense, 5′-AATTCTCGAGCCC AGCATGCTTAGACATGGTTCTGCTCGAG-3′; anti-sense, 5′-CTCGAGCAGAA CCATGTCTAAGCATGCTGGGCTCGAGAATT-3′) as DNA probes and subjected them to 5′-end labeling by polynucleotide kinase using [γ-32 P] ATP (3000 Ci/mmol) and T4 polynucleotide kinase (Roche, Basel, Switzerland) according to the manufacturer's instructions. The indicated amount of purified Metnase and/or hPso4 was incubated with 200 fmol of labeled DNA at room temperature for 15 min in a reaction mixture containing
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Immunoblotting
We collected the cells with trypsin-EDTA, washed them with phosphatebuffered saline (PBS), and lysed them in a lysis buffer containing PBS, 1% NP-40 (Sigma-Aldrich) and protease inhibitor cocktails (Sigma-Aldrich).
All immunoblotting was conducted as described previously by Smith et al. (38) . The primary antibodies used in this study were as follows: anti-GADD45A (Santa Cruz Biotechnology, Inc.); anti-PCNA (Santa Cruz Biotechnology, Inc.); anti-XPG (Bethyl Laboratories, Inc., Montgomery, TX) and anti-GAPDH (AbFrontier, Seoul, South Korea). We enhanced the chemiluminescent signals using the Amersham ECL plus Western Blotting Detection System according to the manufacturer's recommendations (GE Healthcare, Pittsburgh, PA).
Immunoprecipitation
In order to make a pre-clear supernatant, a 1-mg protein sample in a lysis buffer (150 mM salt conditions containing 1% NP-40, 1× proteinase inhibitor in PBS) was mixed with Protein A Plus Protein G agarose beads (50%/50%; Oncogene Science, Uniondale, NY) and centrifuged the sample for 2-5 min at 5000 rpm at 4°C. We treated the supernatant with 2 μl of GADD45A antibody (Santa Cruz Biotechnology, Inc.) and incubated it for 2 h at 4°C by shaking. The supernatant was then mixed with 50 μl of Protein A Plus Protein G agarose beads (50%/50%) and incubated overnight at 4°C with shaking. The sample was centrifuged for 5 min at 5000 rpm at 4°C. We then washed the sample four times with a washing buffer (150 mM salt containing 1% NP-40 in PBS) for 5 min at room temperature. Subsequently, we added 30 μl of 2× sample buffer and boiled it for 5 min at 95°C. We performed the immunoblotting experiment in order to obtain a band that indicated interaction.
In situ proximity ligation assay
The Duolink assay was performed in accordance with the Duolink in situ-fluorescence manual (Sigma-Aldrich). RKO cells grown on a cover slip were fixed with methanol at −20°C and incubated with Triton X-100 (Sigma-Aldrich) at room temperature. The cover slips were rinsed with chilled acetone. After washing the cover slips with PBS (Gibco), a blocking solution (Sigma-Aldrich) was placed on the cover slips. The primary antibodies were as follows: anti-GADD45A (Santa Cruz Biotechnology, Inc.); anti-XPG (Bethyl Laboratories, Inc.). The cover slips were incubated overnight with the primary antibodies. The cover slips were treated with PLA plus and minus probes (Sigma-Aldrich) for 1 h, followed by washing with wash buffer A. Subsequently, the cover slips underwent a process including ligation and amplification using the Duolink in situ-fluorescence kit followed by mounting on a slide glass. Fluorescent foci on the cover slips were detected under a confocal microscope (Nikon, Tokyo, Japan) and analyzed using NIS Elements AR 3.0 software (Nikon) to assess the intensity means of the fluorescent foci in the cells.
Transfection of GADD45A siRNA
The GADD45A siRNA and control siRNA were obtained from Ambion (Austin, TX). The transfection of RKO cells was accomplished using the oligofectamine reagent (Invitrogen, Waltham, MA) according to the manufacturer's instructions with single strand sense and antisense RNA oligonucleotides (sense, 5′-AGUCGCUACAUGGAUCAAUtt-3′; antisense, 5′-AUUGAUCCAUGUAGCGACUtt-3′). The RKO cells were plated on sixwell plates and incubated for 12-16 h prior to transfection. The cells were washed once with fresh medium and 0.2 μM siRNA diluted in RPMI was added. In a separate tube, 6 μl of the oligofectamine transfection reagent was mixed with RPMI and incubated for 10 min at room temperature. The diluted siRNA samples were mixed with the oligofectamine mixtures 20 min later, the mixtures were treated to the RKO cells. After incubation for 4 h, 0.5 ml of culture medium containing 30% FBS was added without removing the transfection mixture. After incubation for 72 h, the cell lysates were prepared and examined using immunoblotting to assess the efficacy of the siRNA treatment.
6-4 photoproducts ELISA assay
RKO cells were cultured in the presence of 20 μM nickel for 24 h. The medium was removed and then the cells with irradiated with UV light for 30 s. The growth medium was added and the sample was incubated for various times (10 min, 1 h, 2 h and 4 h). DNA of each sample was purified using the high pure PCR template preparation Kit (Roche, Switzerland). The purified DNA was denatured at 100°C for 10 min, and transferred evenly (50 μl/well) to protamine sulfate-coated 96-well plates and dried completely at 37°C. The DNA-coated plates were washed with PBS-T (0.05% Tween-20 in PBS). In each well, 150 μl of 2% FBS in PBS was added, and the plates were incubated for 30 min at 37°C. After washing with PBS-T, 100 μl of anti-6-4 photoproducts antibodies (Cosmobio Co., Tokyo, Japan) diluted with PBS (1:2000) was added to each well, and incubated for 1 h at 37°C. After washing the plates with PBS-T, 100 μl of goat anti-mouse IgG:HRP conjugate (Santa Cruz Biotechnology, Inc.) diluted with PBS (1:2000) was added to each well and incubated for 1 h at 37°C. Then, the plates were washed with PBS-T, and 100 μl of BM blue peroxidase substrate (Roche, Switzerland) diluted with PBS was placed in each well. After mixing gently, the absorbance at 415 nm was determined with a microplate reader (Bio-Rad, Hercules, CA).
Statistical analysis
All data are presented as the sample mean ± SD. The significance of the difference between the experimental groups and control was assessed by Student's t-test. P values less than 0.05 were considered statistically significant.
Results
Alteration of TP53 functional structure and its activity in downstream transcription under nickel exposure
To investigate our hypothesis that nickel induces genomic instability by disturbing p53-downstream pathway via alteration of its functional state, we first examined the change in p53 oligomerization in response to nickel to understand functional form of p53. Although p53 can exist in monomeric and dimeric forms in normal conditions (39) , it activates transcription most efficiently when it is tetrameric (40) . Because zinc-binding residues in p53 protein are located in the DNA-binding domain as well as the p53 tetramerization domain (41), we used zinc as a positive control. Likewise, our result of protein cross-linking assay using RKO cell line, which contains a wild-type p53, showed an increased level of oligomers in zinc-treated group ( Figure 1A ). By contrast, the p53 oligomerization were diminished under nickel. In order to confirm this result, we used electron microscopy, and we considered particles > 10 nm to be p53 tetramers based on the p53 particle size suggested in previous electron microscopy research (41) ; the p53 structure analyses of the purified protein from yeast revealed that p53 tetramer formation decreased in response to nickel ( Figure 1B) . Furthermore, in order to identify the effect of nickel on p53 downstream genes, we observed the p53 activity at its binding site in GADD45A using an electrophoretic mobility shift assay ( Figure 1C) . To activate the stress-response gene, GADD45A, UV radiation was used as an exogenous stressor. Nickel-treated cells showed decreased protein-DNA binding at the p53-binding site in GADD45A. These results suggest that low concentrations of nickel interfere with the transcriptional activity of p53 by disturbing the formation of p53 tetramer, its functional state.
Disturbance of physical interaction between TP53-mediated NER proteins in response to nickel
Based on nickel's interference in GADD45A expression by p53, we investigated the effects of nickel on the interactions among GADD45A-mediated NER proteins. GADD45A is one of the main contributors to DNA repair via the p53-mediated pathway. As mentioned earlier, it plays a crucial role in maintaining genomic integrity by direct interaction with core proteins of the NER machinery, PCNA and XPG. In this study, we examined the alteration of their protein level by nickel exposure in both RKO cells and NHDF. The level of p53 was barely different in control and nickel-treated groups. On the other hands, as a result of the disturbance in p53 oligomerization by nickel, the protein level of GADD45A was declined (Figure 2 ). Although only GADD45A expression decreased conspicuously, an immunoprecipitation experiment showed that the protein interactions of GADD45A with PCNA or XPG were clearly decreased by 20 μM nickel. We additionally performed an in situ proximity ligation assay (Supplementary Figure 1 , available at Carcinogenesis Online) to confirm the decreased interaction between GADD45A and XPG under nickel exposure in RKO cells. Likewise, the proteins of p53-downstream NER machinery in NHDF were affected by nickel, showing a similar tendency with RKO cells. Consequently, these results suggest that nickel exposure interrupts the interactions between major factors of the NER mechanism, thereby reducing DNA repair capacity by nickel-induced disturbance in p53-and GADD45A-mediated mechanisms.
Nickel enhancement of DNA repair inhibition in GADD45A-knockdown cells
Studies in the past have demonstrated that GADD45A-knockout models both in vitro and in vivo remove UV radiation-induced DNA damage (42, 43) . In order to investigate the effects of nickel in GADD45A-mediated NER capacity, we used a GADD45A knockdown system by RNA interference. Cells treated with GADD45A siRNA showed clearly diminished protein levels after 24 and 48 h compared with control siRNA-treated cells ( Figure 3A) . We examined DNA repair activity following UVC exposure using an anti (6-4)-photoproducts ELISA under nickel-exposed conditions in both wild-type and GADD45A-knockdown cells. As shown in Figure 3B , DNA damage caused by UVC exposure was repaired after 2 h, whereas nickel-treated cells took two more hours to repair the DNA damage in wild-type cells. These results imply that the effect of nickel in p53 dysfunction can trigger a decline in NER activity. Interestingly, GADD45A-knockdown cells had not completely repaired the DNA damage after 2-4 h, and moreover, the cells with nickel exposure retained the DNA damage to a greater extent than the others after UVC treatment. The combination of nickel exposure and GADD45A deficiency seriously hampers UV-induced DNA damage repair. Therefore, our data indicate not only that GADD45A plays a clear role as a key NER modulator by physical interaction, but also that disturbance of p53-downstream and GADD45A-mediated NER may be considered a carcinogenic molecular mechanism in response to nickel exposure.
Discussion
A threat of nickel to human health has been a problem in modern society, by leading to the development of cancer (5,7). Accordingly, potential mechanisms of nickel-induced carcinogenesis have been investigated in various epidemiologic and experimental studies (44, 45) . Following the studies, nickel is a prominent toxic heavy metal in the management of global public health. Most studies on nickel toxicity have reported nickel-induced disease resulting from acute exposure at high concentrations because nickel metallurgy workers were so easily exposed (44, 46) . However, humans primarily experience nickel-induced toxicity and carcinogenicity through the long-term accumulation of low doses of nickel via inhalation and ingestion (7, 8, 47) . Therefore, it is necessary to clarify the molecular mechanism of low-dose nickel-related carcinogenesis. In order to investigate a carcinogenic effect of low-dose nickel, herein, dose-dependent cytotoxicity of nickel was examined by MTT assay (data not shown), indicating that cell viability was barely affected by nickel at low-dose (~95% viability at 10-30 μM) compared to high dose (around 73% at 100-300 μM).
Then, we selected a 20 μM nickel concentration, which had no effect on the cell cycle 72 h after treatment (data not shown). Interestingly, Hartwig et al. (27, 48) suggested that nickel interfered with the incision step in NER in mammalian cells, but there were few follow-up investigations. In order to propose a novel approach to the molecular mechanism of nickel-induced carcinogenesis following previous studies, we evaluated the alteration in the p53-mediated NER mechanism under low dose of nickel. Nickel has the ability to replace the zinc in the zinc-finger motif, and nickel-substituted zinc-finger proteins lose their intrinsic structure (49) . In fact, p53 needs a zinc ion to maintain stable homotetramers, which are its active form for DNA binding (40) . Along these lines, we demonstrated that the disturbance of p53 oligomerization could be a major cause of the nickel-induced inhibition of p53 binding activity (Figure 1) . Indeed, p53 has a high sensitivity to metals that affect p53 conformation for DNA binding (50) . Following these observations, in this study, we suggested that p53 conformational change by nickel could interfere with the downstream NER pathway, a crucial mechanism for preserving genomic integrity, with the aim of elucidating nickel-induced carcinogenesis. GADD45A is a p53-regulated protein that is critical factor in DNA repair. We identified decreased protein binding at the p53 binding site on GADD45A promoter in response to nickel exposure, diminishing GADD45A level, and this have been caused by a p53 functional defect. This might elucidate how nickel affects the transcriptional function of p53 associated with GADD45A-mediated NER.
GADD45A forms the repairsome in the NER pathway via direct interaction with other repair proteins, such as PCNA and XPG (32, 33) . As mentioned earlier, nickel disturbs the NER activity (27, 28) , but there is still very few molecular evidence for the NER mechanism that has been reported previously. Thus, we focused on the effects of nickel exposure on GADD45A-mediated protein-protein interaction, which is a p53-regulated DNA repair mechanism. In the context of previous reports that nickel compounds disturb the incision step in NER (27) , we observed that nickel exposure inhibits the physical interaction between GADD45A and XPG (Figure 2 ). XPG has a catalytic role in 3′ incision and a non-catalytic function in 5′ incision via ERCC1-XPF during dual incision in NER (51), playing a vital role in NER activity. In our previous study, we predicted the PCNA binding site (amino acids 156-158) on the GADD45A gene sequence using bioinformatic analyses, by elucidating the DNA repair mechanism related to GADD45A (22) . Indeed, as shown in Figure 2 , nickel can interfere with the interaction between GADD45A and PCNA as well. These reductions can be inferred from the disturbance of p53-mediated GADD45A expression by nickel treatment. Furthermore, these outcomes were verified under nickel exposure in normal skin cell line, NHDF. As various studies reported, occupational exposure to ambient nickel give rise to severe skin damage (52) (53) (54) . Identifying a toxic mechanism of nickel exposure is also meaningful to understand nickel-induced skin toxicity. Thus, our finding suggests that nickel diminishes the physical interactions between major factors of NER. The enhancement of DNA repair by GADD45A under toxic conditions is well recognized. According to previous studies, GADD45A deficiency is highly associated with genomic instability and carcinogenesis by reducing the DNA repair capacity (43, 55) . In consequence of the obstruction of functional p53 formation by nickel, the level of GADD45A decreased accordingly. The repair activity on UVC-induced DNA damage was subsequently weakened by nickel exposure (Figure 3) , elucidating the toxic mechanism of nickel on p53-mediated NER process. Meanwhile, the property of nickel which substitute zinc in zinc-finger motif also could have an effect on other protein containing zinc-finger motif, such as XPA (49) . Interestingly, we observed the most intensely impaired DNA repair capacity in nickel-treated GADD45A knockdown cells. Moreover, we found that GADD45A siRNA cells treated with nickel declined their protective effect against UV irradiation, as shown by a colony cell survival assay (data not shown). These results could be interpreted not only that the gap of NER activity between control and nickel-treated group could be modulated by other NER proteins in GADD45A-deficient cells, but also that the NER capacity was significantly dependent on GADD45A, emphasizing the crucial role of GADD45A as NER modulator. Hence, present study suggests that the toxic mechanism of nickel in p53-downsteam pathway in GADD45A-mediated DNA repair, under the concept of gene-environment interaction.
Taken together, the results presented in this study demonstrate a potential toxic mechanism of nickel exposure in terms of inhibiting p53-mediated NER functionality (Figure 4) , by characterizing the interference of nickel at low, non-cytotoxic concentration in p53 oligomerization. Further mechanistic studies should be conducted to understand nickel's effect on the p53 oligomerization by comparing with p53 abnormal form containing mutation in its zincbinding sites. Also, further in vivo study is needed for supporting our present research on nickel's molecular carcinogenic effect on p53-mediated NER process to complement the limitation of in vitro study. Hence, our findings suggested the necessity of additional studies to develop new insights and strategies in the field of environmental health in light of widespread environmental and occupational exposure to nickel compounds in terms of carcinogenicity.
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